Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1375 of 2529 entries
View as:

Assessing Short-term Treatment Satisfaction and Quality of Life in Patients With Hidradenitis Suppurativa Initiated on Secukinumab.

Phase: N/A Priority: Normal
NCT ID: NCT06785675 Org: User:
Start: 03/10/25 End: 11/29/25 Due: 11/29/26

Study of Tisagenlecleucel in Combination With Ibrutinib in r/r Diffuse Large B-cell Lymphoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT03876028 Org: User:
Start: 06/11/19 End: 11/01/21 Due: 11/01/22

Prevention of Thromboembolic Events in Total Knee Replacement Patients

Phase: N/A Priority: Normal
NCT ID: NCT03393481 Org: User:
Start: 10/03/18 End: 04/17/20 Due: 04/17/21

Long-term Extension Study of Ligelizumab in Food Allergy

Phase: N/A Priority: Normal
NCT ID: NCT05678959 Org: User:
Start: 04/27/23 End: 03/06/25 Due: 03/06/26

Effect of LIK066 on Reduction of Fatty Content in Livers of Obese Patients

Phase: N/A Priority: Normal
NCT ID: NCT03205150 Org: User:
Start: 10/04/17 End: 11/14/19 Due: 11/14/20

Implementation Study to Describe and Compare Retention Rate and Adherence to Adjuvant Therapy With Ribociclib With and Without Usage of Mobile Application in Patients With HR+ HER2-negative Stage II and III Breast Cancer in Real-world Practice

Phase: N/A Priority: Normal
NCT ID: NCT06905301 Org: User:
Start: 07/31/25 End: 07/01/29 Due: 07/01/30

Impact of Hepatic Impairment on the Pharmacokinetics of Deferasirox.

Phase: N/A Priority: Normal
NCT ID: NCT00432627 Org: User:
Start: 12/31/06 End: 08/31/10 Due: 08/31/11

Safety, Efficacy and PK/PD of QGE031 vs. Placebo in Patients With Active Bullous Pemphigoid Despite Oral Steroid Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01688882 Org: User:
Start: 01/31/13 End: 03/31/15 Due: 03/31/16

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Phase: N/A Priority: Normal
NCT ID: NCT01436643 Org: User:
Start: 11/30/11 End: 09/30/13 Due: 09/30/14

Sustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT00938860 Org: User:
Start: 09/30/09 End: 05/31/13 Due: 05/31/14

The Gilenya Pregnancy Registry

Phase: N/A Priority: Normal
NCT ID: NCT01285479 Org: User:
Start: 10/15/11 End: 05/29/24 Due: 05/29/25

Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)

Phase: N/A Priority: Normal
NCT ID: NCT01535950 Org: User:
Start: 02/29/12 End: 07/31/13 Due: 07/31/14

Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT02058108 Org: User:
Start: 10/31/14 End: 01/09/19 Due: 01/09/20

Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Central Retinal Vein Occlusion (CRVO)

Phase: N/A Priority: Normal
NCT ID: NCT01976312 Org: User:
Start: 11/12/13 End: 03/14/16 Due: 03/14/17

Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01491672 Org: User:
Start: 11/30/11 End: 05/31/15 Due: 05/31/16

Study of Efficacy and Safety of Eltrombopag in Patients With Poor Graft Function

Phase: N/A Priority: Normal
NCT ID: NCT03718533 Org: User:
Start: 12/17/18 End: 11/03/20 Due: 11/03/21

24 Week Study to Compare Systemic VEGF-levels of Ranibizumab and Aflibercept in DME.

Phase: N/A Priority: Normal
NCT ID: NCT02878681 Org: User:
Start: 09/30/16 End: 09/30/17 Due: 09/30/18

A Study of the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT03481660 Org: User:
Start: 07/27/18 End: 06/08/21 Due: 06/08/22

A Single Arm Study Evaluating the Efficacy, Safety and Tolerability of Ofatumumab in Patients With Relapsing Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT04486716 Org: User:
Start: 10/19/20 End: 10/21/24 Due: 10/21/25

Effect of Glycopyrronium on Morning Symptoms and Pulmonary Function in Patients With Moderate to Severe COPD

Phase: N/A Priority: Normal
NCT ID: NCT01959516 Org: User:
Start: 02/28/14 End: 10/31/14 Due: 10/31/15

Non-small Cell Lung Cancer Study US75 (Z-PACT)

Phase: N/A Priority: Normal
NCT ID: NCT00086268 Org: User:
Start: 04/30/04 End: 10/31/07 Due: 10/31/08

Efficacy of NVA237 (50 μg o.d) Using Tiotropium (5μg μg o.d) as Active Control in COPD Patients.

Phase: N/A Priority: Normal
NCT ID: NCT01837927 Org: User:
Start: 04/30/14 End: 04/30/16 Due: 04/30/17

Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease.

Phase: N/A Priority: Normal
NCT ID: NCT00731224 Org: User:
Start: 07/31/08 End: 10/31/11 Due: 10/31/12

Safety Study of LBH589 When Given in Combination With Lenalidomide and Dexamethasone in Adult Patients With Multiple Myeloma.

Phase: N/A Priority: Normal
NCT ID: NCT00532675 Org: User:
Start: 04/22/08 End: 11/08/17 Due: 11/08/18

Real-World Assessment of Clinical Outcomes in Metastatic NSCLC Patients With MET Exon 14 Skipping Mutation and Brain Metastases Treated With Capmatinib

Phase: N/A Priority: Normal
NCT ID: NCT05675683 Org: User:
Start: 10/01/21 End: 12/31/21 Due: 12/31/22